JYNARQUE – Otsuka America
This is the first and only FDA-approved treatment proven to slow kidney function decline in adults who are at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). The patient testimonials that appear on the JYNARQUE.com site are inspiring stories of how the drug has given hope to a new generation of ADPKD sufferers. Visit https://www.jynarque.com/patient-stories
to see the stories.